Advertisement

Drugs in R & D

, Volume 6, Issue 3, pp 186–188 | Cite as

Ramelteon

TAK 375
Adis R&D Profile

Keywords

Melatonin Anxiety Disorder Zolpidem Triazolam Ramelteon 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Takeda Pharmaceuticals North America. Takeda Submits New Drug Application for Ramelteon, an Investigational Sleep Drug. Media Release: 24 Sep 2004. Available from URL: http://www.tpna.com Google Scholar
  2. 2.
    Takeda Pharmaceuticals North America. Takeda Pharmaceuticals North America Shares Early Stage Data on Sleep Compound, TAK-375. Media Release: 21 May 2003. Available from: URL http://www.takedapharm.com Google Scholar
  3. 3.
    Stubbs CM, Karim A. Safety, pharmacokinetics, and pharmacodynamics of TAK-375 in healthy adults. American Psychiatric Association 2003 Annual Meeting: Syllabus and Proceedings Summary: 25–26, 17 May 2003Google Scholar
  4. 4.
    Stevenson S, Bryson S, Amakye D, et al. Study to investigate the absolute bioavailability of a single oral dose of ramelteon (TAK-375) in healthy male subjects. Clinical Pharmacology and Therapeutics 75: 22, No. 2, Feb 2004Google Scholar
  5. 5.
    Miyamoto M, Nishikawa H, Ohta H. et al. Pharmacological effects of TAK-375, a ML1-selective melatonin receptor agonist, in experimental animals. International Journal of Neuropsychopharmacology 3 (Suppl. 1): 213, Jul 2000Google Scholar
  6. 6.
    Miyamoto M, Nishikawa H, Hirai K, et al. Sleep-promoting action and pharmacological effects of TAK-375, a novel ML1-selective melatonin receptor agonist, in experimental animals. Japanese Journal of Pharmacology 85 (Suppl. I): 257 (plus poster), 2001Google Scholar
  7. 7.
    Kato K, Uchikawa O, Fukatsu K, et al. Neuropharmacological properties of TAK-375, a novel ML1-seleceive melatonin receptor agonist. International Journal of Neuropsychopharmacology 3 (Suppl. 1): 214–215, Jul 2000Google Scholar
  8. 8.
    Kato K, Hirai K, Uchikawa O, et al. Neuropharmacological properties of TAK-375, a novel melatonin ML1 receptor agonist. Japanese Journal of Pharmacology 85 (Suppl. I): 257 (plus poster), 2001Google Scholar
  9. 9.
    Yukuhiro N, Kimura H, Nishikawa H, et al. Effects of TAK-375, a novel melatonin receptor agonist, on sleep in freely moving monkeys. International Journal of Neuropsychopharmacology 3 (Suppl. 1): 214, Jul 2000Google Scholar
  10. 10.
    Yukuhiro N, Nishikawa H, Kimura H, et al. Effects of TAK-375, a novel melatonin receptor agonist, on sleep in freely moving monkeys at nighttime. Japanese Journal of Pharmacology 85 (Suppl. I): 257 (plus poster), 2001Google Scholar
  11. 11.
    Simpson R. News from the APSS meeting. Inpharma 1402: 10–11, 30 Aug 2003CrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2005

Personalised recommendations